302 related articles for article (PubMed ID: 16773198)
1. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
[TBL] [Abstract][Full Text] [Related]
2. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan mediates adhesion of metastatic colon carcinoma cells.
Laurich C; Wheeler MA; Iida J; Neudauer CL; McCarthy JB; Bullard KM
J Surg Res; 2004 Nov; 122(1):70-4. PubMed ID: 15522317
[TBL] [Abstract][Full Text] [Related]
4. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
[TBL] [Abstract][Full Text] [Related]
5. Effect of a hyaluronan synthase suppressor, 4-methylumbelliferone, on B16F-10 melanoma cell adhesion and locomotion.
Kudo D; Kon A; Yoshihara S; Kakizaki I; Sasaki M; Endo M; Takagaki K
Biochem Biophys Res Commun; 2004 Sep; 321(4):783-7. PubMed ID: 15358095
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
[TBL] [Abstract][Full Text] [Related]
7. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI
Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
[TBL] [Abstract][Full Text] [Related]
9. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production.
Hiraga T; Ito S; Nakamura H
Cancer Res; 2013 Jul; 73(13):4112-22. PubMed ID: 23633482
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity.
Dunn KM; Lee PK; Wilson CM; Iida J; Wasiluk KR; Hugger M; McCarthy JB
Surgery; 2009 Mar; 145(3):322-9. PubMed ID: 19231585
[TBL] [Abstract][Full Text] [Related]
13. Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).
Morohashi H; Kon A; Nakai M; Yamaguchi M; Kakizaki I; Yoshihara S; Sasaki M; Takagaki K
Biochem Biophys Res Commun; 2006 Jul; 345(4):1454-9. PubMed ID: 16730656
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration.
Berdiaki A; Datsis GA; Nikitovic D; Tsatsakis A; Katonis P; Karamanos NK; Tzanakakis GN
IUBMB Life; 2010 May; 62(5):377-86. PubMed ID: 20222016
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
16. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
17. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
18. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
[TBL] [Abstract][Full Text] [Related]
19. A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells.
Yoshihara S; Kon A; Kudo D; Nakazawa H; Kakizaki I; Sasaki M; Endo M; Takagaki K
FEBS Lett; 2005 May; 579(12):2722-6. PubMed ID: 15862315
[TBL] [Abstract][Full Text] [Related]
20. The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells.
Vigetti D; Rizzi M; Viola M; Karousou E; Genasetti A; Clerici M; Bartolini B; Hascall VC; De Luca G; Passi A
Glycobiology; 2009 May; 19(5):537-46. PubMed ID: 19240269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
